Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

FACULTY

James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
Lipidology & Cardiovascular Disease Prevention
Diplomate American Board of Clinical Lipidology
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President National Lipid Association
President American Board of Clinical Lipidology

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Clinical Pharmacist Specialist, Primary Care
Grady Health System
Atlanta, GA

FINANCIAL DISCLOSURE

Dr. Cheeley hereby states that he does not have relevant affiliation or financial relationship or relationship to products or devices with a commercial interest related to the content of this activity to disclose.

Dr. Underberg discloses the following relationships:
     Consulting Fees: Amgen, Esperion, Novartis
     Speakers Bureau: Alexion, Amarin, Amgen, Amyrt, Esperion
     Contracted Research: Amyrt Pharma

The following reviewer, Ben Caref, PhD. states that he has no financial relationship or relationship to products or devices with a commercial interest related to the content of this activity to disclose.

Susanne Batesko, RN, BSN, and Robin Carrino, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

ACCREDITATION STATEMENTS

PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-21-039-L01-P
Credits: 0.50 hour (0.05 CEUs)

Type of Activity: Knowledge
Media: Internet

Fee Information: There is no fee for this educational activity.
Estimated time to complete activity: 90 minutes

Dates of ActivitY

March 13, 2021
5:30 PM ET

TARGET AUDIENCE

This activity is designed to meet the educational needs of retail, hospital and managed care pharmacists.

HOW TO OBTAIN CREDIT

Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live educational activity; and 3) complete the evaluation form directly after the event with a maximum of within 60 days of attending the webinar. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your credit will automatically be uploaded to the CPE Monitor.

IMPORTANT: To claim credit, you must have been in attendance through your computer and have watched and listened to the live webinar in its entirety, attending the full 30-minute activity.  Participants that have listened only via telephone are not eligible to earn credit.  Postgraduate Healthcare Education, LLC has the right to deny credit to individuals that have not attended and participated in this webinar in its entirety. Postgraduate Healthcare Education, LLC completes audits of attendees on a routine basis to ensure compliance with all ACPE standards.

Goal

During this interactive and engaging activity, we will focus on addressing the pharmacist’s role in treating patients with atherosclerotic cardiovascular disease (ASCVD) and at further risk of events beyond LDL-C lowering with statins.

LEARNING OBJECTIVES

At the conclusion of this program, the learner will be able to do the following:

• Discuss the LDL-C-lowering and other pathways to reduce ASCVD events
• Review evidence on the clinical utility of adjuncts to statin therapy to improve management of patients with or at high risk of ASCVD events

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac & Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Peripherals: Computer speakers or headphones
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use and Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC, Medtelligence or Amarin Pharma, Inc. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without an evaluation of their patients’ conditions and current medications, including the identification of possible contraindications regarding the dangers of use and a review of any applicable manufacturer’s product information, as well as a comparison with the recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer’s package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.

Take Exam